Plasma EGF levels predict cognitive decline in Parkinson's Disease

OBJECTIVE: Most people with Parkinson's disease (PD) eventually develop cognitive impairment (CI). However, neither the timing of onset nor the severity of cognitive symptoms can be accurately predicted. We sought plasma-based biomarkers for CI in PD. METHODS: A discovery cohort of 70 PD patien...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chen-Plotkin, Alice S., Hu, William T., Siderowf, Andrew, Weintraub, Daniel, Gross, Rachel Goldmann, Hurtig, Howard I., Xie, Sharon X., Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., McCluskey, Leo, Elman, Lauren, Van Deerlin, Vivianna M., Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155276/
https://ncbi.nlm.nih.gov/pubmed/21520231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22271
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller